Valence8 US
Latest statistics and disclosures from Valence8 US's latest quarterly 13F-HR filing:
- Top 5 stock holdings are QUAL, QQQ, IQLT, EFV, VTV, and represent 77.12% of Valence8 US's stock portfolio.
- Added to shares of these 10 stocks: QUAL (+$6.5M), QQQ (+$5.6M), IQLT (+$5.6M), AZN, AMGN, SLNO, INSM, JAZZ, BMY, ASND.
- Started 47 new stock positions in APLS, SLNO, TYRA, ELYM, KROS, LLY, NTLA, ENTA, VTGN, IOVA.
- Reduced shares in these 4 stocks: VTV, XLU, EWU, XLP.
- Valence8 US was a net buyer of stock by $38M.
- Valence8 US has $241M in assets under management (AUM), dropping by 25.66%.
- Central Index Key (CIK): 0001943819
Tip: Access up to 7 years of quarterly data
Positions held by Valence8 US consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Valence8 US
Valence8 US holds 56 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Msci Usa Qlt Fct (QUAL) | 25.1 | $61M | +12% | 338k | 179.30 |
|
| Invesco Qqq Tr Unit Ser 1 (QQQ) | 17.8 | $43M | +14% | 88k | 488.07 |
|
| Ishares Tr Msci Intl Qualty (IQLT) | 17.7 | $43M | +15% | 1.0M | 41.49 |
|
| Ishares Tr Eafe Value Etf (EFV) | 9.5 | $23M | 399k | 57.53 |
|
|
| Vanguard Index Fds Value Etf (VTV) | 7.0 | $17M | -3% | 97k | 174.57 |
|
| Select Sector Spdr Tr Sbi Cons Stpls (XLP) | 5.7 | $14M | 165k | 83.00 |
|
|
| Ishares Tr Msci Uk Etf New (EWU) | 3.2 | $7.8M | -3% | 209k | 37.41 |
|
| Ishares Msci Jpn Etf New (EWJ) | 3.2 | $7.8M | 109k | 71.54 |
|
|
| Astrazeneca Sponsored Adr Call Option (AZN) | 2.1 | $5.0M | NEW | 64k | 77.91 |
|
| Select Sector Spdr Tr Sbi Int-utils (XLU) | 1.7 | $4.2M | -6% | 52k | 80.78 |
|
| Amgen Put Option (AMGN) | 0.5 | $1.3M | NEW | 4.0k | 322.21 |
|
| Soleno Therapeutics (SLNO) | 0.5 | $1.1M | NEW | 22k | 50.49 |
|
| Insmed Com Par $.01 Call Option (INSM) | 0.4 | $1.1M | NEW | 15k | 73.00 |
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.4 | $999k | NEW | 9.0k | 111.41 |
|
| Bristol Myers Squibb (BMY) | 0.4 | $920k | NEW | 18k | 51.74 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.3 | $685k | NEW | 4.6k | 149.31 |
|
| Ultragenyx Pharmaceutical Call Option (RARE) | 0.3 | $619k | NEW | 11k | 55.55 |
|
| Crispr Therapeutics Namen Akt Call Option (CRSP) | 0.3 | $615k | NEW | 13k | 46.98 |
|
| Indivior Ord (INDV) | 0.2 | $564k | NEW | 57k | 9.85 |
|
| Eli Lilly & Co. (LLY) | 0.2 | $561k | NEW | 633.00 | 885.94 |
|
| Argenx Se Sponsored Adr (ARGX) | 0.2 | $517k | NEW | 953.00 | 542.08 |
|
| Keros Therapeutics (KROS) | 0.2 | $466k | NEW | 8.0k | 58.07 |
|
| Novo-nordisk A S Adr Call Option (NVO) | 0.2 | $464k | NEW | 3.9k | 119.07 |
|
| Janux Therapeutics Put Option (JANX) | 0.2 | $461k | NEW | 10k | 45.43 |
|
| Nuvalent Inc-a (NUVL) | 0.2 | $421k | NEW | 4.1k | 102.30 |
|
| Cassava Sciences Put Option (SAVA) | 0.2 | $415k | NEW | 14k | 29.43 |
|
| Apellis Pharmaceuticals Call Option (APLS) | 0.2 | $378k | NEW | 13k | 28.84 |
|
| Avadel Pharmaceuticals Com Shs Call Option (AVDL) | 0.1 | $344k | NEW | 26k | 13.12 |
|
| Crinetics Pharmaceuticals In (CRNX) | 0.1 | $342k | NEW | 6.7k | 51.10 |
|
| Tyra Biosciences (TYRA) | 0.1 | $310k | NEW | 13k | 23.51 |
|
| Apogee Therapeutics (APGE) | 0.1 | $308k | NEW | 5.2k | 58.74 |
|
| Altimmune Com New Put Option (ALT) | 0.1 | $305k | NEW | 50k | 6.14 |
|
| Miragen Therapeutics Call Option (VRDN) | 0.1 | $298k | NEW | 13k | 22.75 |
|
| Vaxcyte (PCVX) | 0.1 | $282k | NEW | 2.5k | 114.27 |
|
| Moderna Call Option (MRNA) | 0.1 | $274k | NEW | 4.1k | 66.83 |
|
| Intellia Therapeutics (NTLA) | 0.1 | $268k | NEW | 13k | 20.55 |
|
| Vir Biotechnology (VIR) | 0.1 | $252k | NEW | 34k | 7.49 |
|
| Blueprint Medicines (BPMC) | 0.1 | $242k | NEW | 2.6k | 92.50 |
|
| Celldex Therapeutics Com New Put Option (CLDX) | 0.1 | $221k | NEW | 6.5k | 33.99 |
|
| Enanta Pharmaceuticals (ENTA) | 0.1 | $207k | NEW | 20k | 10.36 |
|
| Relay Therapeutics (RLAY) | 0.1 | $186k | NEW | 26k | 7.08 |
|
| Applied Therapeutics Call Option (APLT) | 0.1 | $173k | NEW | 20k | 8.50 |
|
| Zevra Therapeutics Com New (ZVRA) | 0.1 | $150k | NEW | 22k | 6.94 |
|
| Erasca (ERAS) | 0.1 | $128k | NEW | 47k | 2.73 |
|
| Iovance Biotherapeutics Call Option (IOVA) | 0.1 | $123k | NEW | 13k | 9.39 |
|
| Solid Biosciences Com New (SLDB) | 0.0 | $110k | NEW | 16k | 6.97 |
|
| Vistagen Therapeutics Ord (VTGN) | 0.0 | $104k | NEW | 34k | 3.01 |
|
| BioCryst Pharmaceuticals Call Option (BCRX) | 0.0 | $100k | NEW | 13k | 7.60 |
|
| Zura Bio Class A Ord Shs (ZURA) | 0.0 | $71k | NEW | 18k | 4.06 |
|
| Alector (ALEC) | 0.0 | $69k | NEW | 15k | 4.66 |
|
| Eliem Therapeutics (ELYM) | 0.0 | $61k | NEW | 12k | 5.09 |
|
| C4 Therapeutics Com Stk Call Option (CCCC) | 0.0 | $60k | NEW | 11k | 5.70 |
|
| Leap Therapeutics Com New (LPTX) | 0.0 | $48k | NEW | 19k | 2.57 |
|
| Nektar Therapeutics (NKTR) | 0.0 | $34k | NEW | 26k | 1.30 |
|
| Gossamer Bio Call Option (GOSS) | 0.0 | $20k | NEW | 21k | 0.99 |
|
| Kezar Life Sciences (KZR) | 0.0 | $16k | NEW | 21k | 0.77 |
|
Past Filings by Valence8 US
SEC 13F filings are viewable for Valence8 US going back to 2022
- Valence8 US 2024 Q3 filed Nov. 12, 2024
- Valence8 US 2024 Q2 filed Aug. 6, 2024
- Valence8 US 2024 Q1 filed May 6, 2024
- Valence8 US 2023 Q4 filed Feb. 1, 2024
- Valence8 US 2023 Q3 filed Nov. 9, 2023
- Valence8 US 2023 Q2 filed Aug. 1, 2023
- Valence8 US 2023 Q1 filed May 9, 2023
- Valence8 US 2022 Q4 filed Jan. 31, 2023